Comparisons of CYP2D messenger RNA splice variant profiles in human lung tumors and normal tissues

Cancer Research

Volumn 57, Issue 13, 1997, Pages 2589-2592

  Huang, Zeqi ^a   Fasco, Michael J ^a,b   Spivack, Simon ^a,c   Kaminsky, Laurence S ^a,b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b WADSWORTH CENTER   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; MESSENGER RNA;

ADULT; AGED; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG CARCINOMA; MALE; PRIORITY JOURNAL; RNA SPLICING;

ADULT; AGED; BLOTTING, SOUTHERN; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; RNA, MESSENGER; VARIATION (GENETICS);

EID: 0030789095     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ayesh, R., Idle, J. R., and Ritchie, J. C. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature (Lond.), 312: 169-170, 1984.
2. Bouchardy, C., Benhamou, S., and Dayer, P. The effect of tobacco on lung cancer risk depends, on CYP2D6 activity. Cancer Res., 56: 251-253, 1996.
3. Caporaso, N. E., Hayes, R., Dosemeci, M., Hoover, R. N., Ayesh, R., Hetzel, M., and Idel, J. R. Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype. Cancer Res., 49: 3675-3679, 1989.
4. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S., Karjalainen, A., Pelkonen, O., and Vainio, H. PCR-based CYP2D6 genotyping for Finnish lung cancer patients. Pharmacogenetics, 3: 19-27, 1993.
5. Roots, I., Brockmöller, J., Drakoulis, N., and Loddenkemper, R. Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyl-transferase in lung cancer patients. Klin. Wochcnschr., 70: 307-319, 1992.
6. Crespi, C. L., Penman, B. W., Gelboin, H. V., and Gonzalez, F. J. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis (Lond.), 12: 1197-1201, 1991.
7. Distlerath, L. M., Reilly, P. E. B., Martin, M. V., Davis, G. G., Wilkinson, G. R., and Guengerich, F. P. Purification and characterization of the human liver cytochrome P450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem., 260: 9057-9067, 1985.
8. Daly, A. K., Cholerton, S., Armstrong, M., and Idle, J. R. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ. Health Perspect. 102(Suppl. 9): 55-61, 1994.
9. Kimura, S., Umeno, M., Skoda, R. C., Meyer, U. A., and Gonzalez, F. J. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polyrphic CYP2D6 gene, a related gene, and a pseudogene. Am. J. Hum. Genet., 45: 889-904, 1989.
10. Heim, M. H., and Meyer, U. A. Evolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6. Genomics, 14: 49-58, 1992.
11. Huang, Z., Fasco, M. J., and Kaminsky, L. S. Alternative splicing of cytochrome P450 mRNA, CYP2D in human breast tissue. Arch. Biochem. Biophys., in press, 1997.
12. Huang, Z., Fasco, M. J., and Kaminsky, L. S. Optimization of DNase I removal of contaminating DNA from RNA for use in quantitative RNA-PCR. BioTechniques, 20: 1012-1020, 1996.
13. Fasco, M. J., Treanor, C. P., Spivack, S., Figge, H. L., and Kaminsky, L. S. Quantitative RNA-polymerase chain reactions-DNA analysis by capillary electro-pherosis and laser-induced fluorescence. Anal. Biochem., 224: 140-147, 1995.
14. Huang, Z., Fasco, M. J., Figge, H. L., Keoymarsi, K., and Kaminsky, L. S. Expression of cytochrome P450s in human breast tumor and normal tissues. Drug Metab. Dispos., 24: 899-905, 1996.
15. Czerwinski, M., McLemore, T. L., Gelboin, H. V., and Gonzalez, F. J. Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res., 54: 1085-1091, 1994.
16. McLemore, T. L., Adelberg, S., Liu, M. C., McMahon, N. A., Yu, S. J., Hubbard, W. C., Czerwinski, M., Wood, T. G., Storeng, R., Lubet, R. A., Eggleston, J. C., Boyd, M. R., and Hines, R. N. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J. Natl. Cancer Inst., 82: 1333-1339, 1990.